Orphan Technologies Competitors and Similar CompaniesClear all

Orphan Technologies's competitors and similar companies include Aeglea, Cipla, Ipsen and Vertex Pharmaceuticals.

	Orphan Technologies Orphan Technologies is a biotech company developing a drug for homocystinuria.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Ipsen Ipsen is a biopharmaceutical company.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Founding Date	Founding Date N/A	Founding Date 2013	Founding Date 1935	Founding Date 1929	Founding Date 1989
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Rapperswil-Jona, CH HQ	Locations Austin, US HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more
Employees	Employees 1	Employees 65117% increase	Employees 27,764	Employees 5,358	Employees 5,40013% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 48.6 m	Valuation ($) N/A	Valuation ($) 10.2 b	Valuation ($) 121.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) $12b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods €659.1m (FY, 2025)	Cost of goods $1.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit €3.3b (FY, 2025)	Gross profit $10.4b (FY, 2025)
Net income	Net income N/A	Net income ($155.2m) (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income €445.1m (FY, 2025)	Net income N/A
Operating ⚠
Products	Products N/A	Products N/A	Products 1.5 k (FY, 2024)	Products N/A	Products 6 (FY, 2022)